Listed

Kalaris Therapeutics, Inc.

KLRSNasdaqCIK 1754068HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$12.4m, Q2 FY2026
Net income−$11.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m34.2Research and development, Q3 FY2023, three months to 2023-09-30$34.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-11-02, accession 0000950170-23-058145.Report this figure33.4Research and development, Q4 FY2023, three months to 2023-12-31$33.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-07, accession 0000950170-25-035143. Derived: 12-month figure less the 9-month figure.Report this figure2.0Research and development, Q1 FY2024, three months to 2024-03-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure3.2Research and development, Q2 FY2024, three months to 2024-06-30$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure36.0Research and development, Q3 FY2024, three months to 2024-09-30$36.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure3.9Research and development, Q4 FY2024, three months to 2024-12-31$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure6.0Research and development, Q1 FY2025, three months to 2025-03-31$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure8.4Research and development, Q2 FY2025, three months to 2025-06-30$8.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure9.1Research and development, Q3 FY2025, three months to 2025-09-30$9.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure7.2Research and development, Q4 FY2025, three months to 2025-12-31$7.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure7.6Research and development, Q1 FY2026, three months to 2026-03-31$7.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure9.0Research and development, Q2 FY2026, three months to 2026-06-30$9.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Operating income$m(47.0)Operating income, Q3 FY2023, three months to 2023-09-30−$47.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure(62.4)Operating income, Q4 FY2023, three months to 2023-12-31−$62.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-07, accession 0000950170-25-035143. Derived: 12-month figure less the 9-month figure.Report this figure(2.6)Operating income, Q1 FY2024, three months to 2024-03-31−$2.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure(4.2)Operating income, Q2 FY2024, three months to 2024-06-30−$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure(37.8)Operating income, Q3 FY2024, three months to 2024-09-30−$37.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(7.1)Operating income, Q4 FY2024, three months to 2024-12-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Operating income, Q1 FY2025, three months to 2025-03-31−$10.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(12.3)Operating income, Q2 FY2025, three months to 2025-06-30−$12.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure(12.7)Operating income, Q3 FY2025, three months to 2025-09-30−$12.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(10.8)Operating income, Q4 FY2025, three months to 2025-12-31−$10.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure(11.8)Operating income, Q1 FY2026, three months to 2026-03-31−$11.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(12.4)Operating income, Q2 FY2026, three months to 2026-06-30−$12.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Interest expense$mnot reportednot reported0.1Interest expense, Q1 FY2024, three months to 2024-03-31$78.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure0.5Interest expense, Q2 FY2024, three months to 2024-06-30$499.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure0.8Interest expense, Q3 FY2024, three months to 2024-09-30$815.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure1.3Interest expense, Q4 FY2024, three months to 2024-12-31$1.3m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure(0.1)Income tax, Q4 FY2023, three months to 2023-12-31−$126.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-07, accession 0000950170-25-035143. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-05-13, accession 0000950170-24-058607.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-08-09, accession 0000950170-24-094380.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reported
Net income$m(44.3)Net income, Q3 FY2023, three months to 2023-09-30−$44.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure(59.7)Net income, Q4 FY2023, three months to 2023-12-31−$59.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-07, accession 0000950170-25-035143. Derived: 12-month figure less the 9-month figure.Report this figure(3.4)Net income, Q1 FY2024, three months to 2024-03-31−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(5.7)Net income, Q2 FY2024, three months to 2024-06-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(38.1)Net income, Q3 FY2024, three months to 2024-09-30−$38.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(22.0)Net income, Q4 FY2024, three months to 2024-12-31−$22.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure(10.2)Net income, Q1 FY2025, three months to 2025-03-31−$10.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure(11.4)Net income, Q2 FY2025, three months to 2025-06-30−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure(11.9)Net income, Q3 FY2025, three months to 2025-09-30−$11.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(10.0)Net income, Q4 FY2025, three months to 2025-12-31−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure(10.9)Net income, Q1 FY2026, three months to 2026-03-31−$10.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure(11.5)Net income, Q2 FY2026, three months to 2026-06-30−$11.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Diluted EPS$ per share(0.39)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figurenot reported(2.60)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$2.60 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure(4.26)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$4.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure(28.16)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$28.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figurenot reported(2.52)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$2.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(0.61)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure(0.64)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figurenot reported(0.46)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(0.48)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Basic EPS$ per share(0.39)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.39 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figurenot reported(2.60)Basic EPS, Q1 FY2024, three months to 2024-03-31−$2.60 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure(4.26)Basic EPS, Q2 FY2024, three months to 2024-06-30−$4.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure(28.16)Basic EPS, Q3 FY2024, three months to 2024-09-30−$28.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figurenot reported(2.52)Basic EPS, Q1 FY2025, three months to 2025-03-31−$2.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(0.61)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure(0.64)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figurenot reported(0.46)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(0.48)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure

Balance sheet

Cash and equivalents$43.2m, Q2 FY2026
Shareholders' equity$57.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m95.6Cash and equivalents, Q3 FY2023, at 2023-09-30$95.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure90.1Cash and equivalents, FY2023, at 2023-12-31$90.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-07, accession 0000950170-25-035143.Report this figure5.2Cash and equivalents, Q1 FY2024, at 2024-03-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure6.2Cash and equivalents, Q2 FY2024, at 2024-06-30$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure1.9Cash and equivalents, Q3 FY2024, at 2024-09-30$1.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure1.6Cash and equivalents, FY2024, at 2024-12-31$1.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-17, accession 0001193125-26-110659.Report this figure101Cash and equivalents, Q1 FY2025, at 2025-03-31$101.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure88.4Cash and equivalents, Q2 FY2025, at 2025-06-30$88.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure42.4Cash and equivalents, Q3 FY2025, at 2025-09-30$42.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure98.1Cash and equivalents, FY2025, at 2025-12-31$98.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure34.4Cash and equivalents, Q1 FY2026, at 2026-03-31$34.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure43.2Cash and equivalents, Q2 FY2026, at 2026-06-30$43.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Current assets$m220Current assets, Q3 FY2023, at 2023-09-30$220.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058145.Report this figure188Current assets, FY2023, at 2023-12-31$187.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-07, accession 0000950170-25-035143.Report this figure141Current assets, Q1 FY2024, at 2024-03-31$141.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058607.Report this figure130Current assets, Q2 FY2024, at 2024-06-30$129.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094380.Report this figure123Current assets, Q3 FY2024, at 2024-09-30$122.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure2.6Current assets, FY2024, at 2024-12-31$2.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-17, accession 0001193125-26-110659.Report this figure102Current assets, Q1 FY2025, at 2025-03-31$102.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure91.7Current assets, Q2 FY2025, at 2025-06-30$91.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure78.2Current assets, Q3 FY2025, at 2025-09-30$78.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure119Current assets, FY2025, at 2025-12-31$118.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure98.5Current assets, Q1 FY2026, at 2026-03-31$98.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure95.9Current assets, Q2 FY2026, at 2026-06-30$95.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Total assets$m248Total assets, Q3 FY2023, at 2023-09-30$248.3m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-02, accession 0000950170-23-058145.Report this figure191Total assets, FY2023, at 2023-12-31$190.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-07, accession 0000950170-25-035143.Report this figure144Total assets, Q1 FY2024, at 2024-03-31$144.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0000950170-24-058607.Report this figure131Total assets, Q2 FY2024, at 2024-06-30$131.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0000950170-24-094380.Report this figure123Total assets, Q3 FY2024, at 2024-09-30$122.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure6.2Total assets, FY2024, at 2024-12-31$6.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-17, accession 0001193125-26-110659.Report this figure103Total assets, Q1 FY2025, at 2025-03-31$103.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure92.8Total assets, Q2 FY2025, at 2025-06-30$92.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure81.2Total assets, Q3 FY2025, at 2025-09-30$81.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure122Total assets, FY2025, at 2025-12-31$121.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure110Total assets, Q1 FY2026, at 2026-03-31$109.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure99.5Total assets, Q2 FY2026, at 2026-06-30$99.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Current liabilities$m33.1Current liabilities, Q3 FY2023, at 2023-09-30$33.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-02, accession 0000950170-23-058145.Report this figure28.4Current liabilities, FY2023, at 2023-12-31$28.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-07, accession 0000950170-25-035143.Report this figure7.7Current liabilities, Q1 FY2024, at 2024-03-31$7.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0000950170-24-058607.Report this figure2.4Current liabilities, Q2 FY2024, at 2024-06-30$2.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0000950170-24-094380.Report this figure1.4Current liabilities, Q3 FY2024, at 2024-09-30$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure24.7Current liabilities, FY2024, at 2024-12-31$24.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-17, accession 0001193125-26-110659.Report this figure7.1Current liabilities, Q1 FY2025, at 2025-03-31$7.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure7.7Current liabilities, Q2 FY2025, at 2025-06-30$7.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure6.1Current liabilities, Q3 FY2025, at 2025-09-30$6.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure9.7Current liabilities, FY2025, at 2025-12-31$9.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure8.1Current liabilities, Q1 FY2026, at 2026-03-31$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure8.7Current liabilities, Q2 FY2026, at 2026-06-30$8.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Total liabilities$m53.0Total liabilities, Q3 FY2023, at 2023-09-30$53.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-02, accession 0000950170-23-058145.Report this figure45.0Total liabilities, FY2023, at 2023-12-31$45.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-07, accession 0000950170-25-035143.Report this figure23.7Total liabilities, Q1 FY2024, at 2024-03-31$23.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0000950170-24-058607.Report this figure10.7Total liabilities, Q2 FY2024, at 2024-06-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0000950170-24-094380.Report this figure1.4Total liabilities, Q3 FY2024, at 2024-09-30$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure56.8Total liabilities, FY2024, at 2024-12-31$56.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-17, accession 0001193125-26-110659.Report this figure39.2Total liabilities, Q1 FY2025, at 2025-03-31$39.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure39.7Total liabilities, Q2 FY2025, at 2025-06-30$39.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure39.3Total liabilities, Q3 FY2025, at 2025-09-30$39.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure42.9Total liabilities, FY2025, at 2025-12-31$42.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure41.2Total liabilities, Q1 FY2026, at 2026-03-31$41.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure41.9Total liabilities, Q2 FY2026, at 2026-06-30$41.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure
Shareholders' equity$m195Shareholders' equity, Q3 FY2023, at 2023-09-30$195.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure(45.0)Shareholders' equity, FY2023, at 2023-12-31−$45.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-17, accession 0001193125-26-110659.Report this figure(47.5)Shareholders' equity, Q1 FY2024, at 2024-03-31−$47.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(51.5)Shareholders' equity, Q2 FY2024, at 2024-06-30−$51.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(89.4)Shareholders' equity, Q3 FY2024, at 2024-09-30−$89.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure(96.6)Shareholders' equity, FY2024, at 2024-12-31−$96.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure63.9Shareholders' equity, Q1 FY2025, at 2025-03-31$63.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure53.1Shareholders' equity, Q2 FY2025, at 2025-06-30$53.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure41.9Shareholders' equity, Q3 FY2025, at 2025-09-30$41.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure78.8Shareholders' equity, FY2025, at 2025-12-31$78.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure68.6Shareholders' equity, Q1 FY2026, at 2026-03-31$68.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure57.7Shareholders' equity, Q2 FY2026, at 2026-06-30$57.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure

Cash flow

Operating cash flow−$11.0m, Q2 FY2026
Capital expenditure$17.0k, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(34.5)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$34.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125295. Derived: 9-month figure less the 6-month figure.Report this figure(30.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$30.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-07, accession 0000950170-25-035143. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure(4.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0000950170-25-107979. Derived: 6-month figure less the 3-month figure.Report this figure(4.3)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277464. Derived: 9-month figure less the 6-month figure.Report this figure(7.9)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$7.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure(7.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(12.5)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344532. Derived: 6-month figure less the 3-month figure.Report this figure(11.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$11.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277464. Derived: 9-month figure less the 6-month figure.Report this figure(7.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figure(11.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure(11.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$11.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344532. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$17.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-17, accession 0001193125-26-110659. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)23.80m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares84.9Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3084,948,837 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-02, accession 0000950170-23-058145.Report this figure93.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3193,303,672 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0000950170-24-058607.Report this figure94.6Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3094,625,837 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0000950170-24-094380.Report this figure114Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30113,894,188 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125295.Report this figure1.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,312,552 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071339.Report this figure1.3Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,325,706 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0000950170-25-107979.Report this figure1.4Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,352,265 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure4.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-314,053,140 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure18.7Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3018,701,286 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure18.7Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3018,701,708 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277464.Report this figure23.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3123,723,618 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219328.Report this figure23.8Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3023,797,306 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure

Shares outstanding: 23.80mShares outstanding, period not labelled, at 2026-08-0423,804,981 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344532.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.